HeimDVA • NYSE
add
Davita Inc
149,90 $
Fyrir opnun:(0,57%)+0,85
150,75 $
Lokað: 22. apr., 03:45:00 GMT-4 · USD · NYSE · Lagalegir fyrirvarar
Við síðustu lokun
149,33 $
Dagbil
149,46 $ - 151,51 $
Árabil
101,00 $ - 159,42 $
Markaðsvirði
10,01 ma. USD
Meðalmagn
836,50 þ.
V/H-hlutf.
15,76
A/V-hlutfall
-
Aðalkauphöll
NYSE
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | des. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 3,62 ma. | 9,87% |
Rekstrarkostnaður | 659,06 m. | 11,97% |
Nettótekjur | 234,22 m. | -9,68% |
Hagnaðarhlutfall | 6,47 | -17,79% |
Hagnaður á hvern hlut | 3,40 | 51,79% |
EBITDA | 737,91 m. | 12,69% |
Virkt skatthlutfall | 20,05% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | des. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 700,74 m. | -17,17% |
Heildareignir | 17,48 ma. | 1,13% |
Heildarskuldir | 16,32 ma. | 7,42% |
Eigið fé alls | 1,16 ma. | — |
Útistandandi hlutabréf | 66,80 m. | — |
Eiginfjárgengi | -15,72 | — |
Arðsemi eigna | 7,87% | — |
Ávöxtun eigin fjár | 9,79% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | des. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 234,22 m. | -9,68% |
Handbært fé frá rekstri | 540,73 m. | -1,26% |
Reiðufé frá fjárfestingum | -163,13 m. | 34,22% |
Reiðufé frá fjármögnun | -414,52 m. | 26,65% |
Breyting á handbæru fé | -37,67 m. | 86,49% |
Frjálst peningaflæði | 395,96 m. | 16,37% |
Um
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.
The company is ranked 331st on the Fortune 500. Wikipedia
Framkvæmdastjóri
Stofnsett
1992
Höfuðstöðvar
Vefsvæði
Starfsfólk
78.000